Physician

Obstetrics & Gynecology

Lawrence L. Engmann works in the field of Obstetrics & Gynecology. He studied medicine at University of Ghana Medical School. Doctor Lawrence L. Engmann, MD is also published. He has 47 publications published. The lastest publication: "Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.'

Publications

---

• Predictors of participant retention in Infertility treatment trials.
• Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol.
• Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches.
• Concurrent ovarian and ipsilateral tubal Ectopic pregnancies after a double embryo transfer: a case report.
• Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization.
• Dual trigger with gonadotropin-releasing hormone agonist (GnRHa) and standard dose human chorionic gonadotropin (hCG) to improve oocyte maturity rates.
• A prospective pilot study comparing fertilization and embryo development between fresh and vitrified sibling oocytes.
• Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
• Intensive luteal phase support after GnRH agonist trigger: it does help.
• Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
• In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle.
• Selection of first in vitro fertilization cycle stimulation protocol for good prognosis patients: gonadotropin releasing hormone antagonist versus agonist protocols.
• Influence of embryo quality and number of previous cycles on Pregnancy and multiple Pregnancy rates in women aged 35 to 37 years who received two or three embryos.
• Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles.
• Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization.
• Trends in the incidence of births and multiple births and the factors that determine the probability of multiple birth after IVF treatment.
• Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional Ovarian cyst formation: a prospective, randomized ...
• Cumulative probability of clinical Pregnancy and live birth after a multiple cycle IVF package: a more realistic assessment of overall and age-specific success rates?
• The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic Ovarian morphology.
• The pattern of changes in Ovarian stromal and uterine artery blood flow velocities during in vitro fertilization treatment and its relationship with outcome of the cycle.
• Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of Ovarian hyperstimulation syndrome.
• Value of Ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of Ovarian responsiveness and outcome of in vitro fertilization ...
• Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to Ovarian hyperstimulation syndrome and polycystic ova...
• A prospective randomized study to assess the clinical efficacy of gonadotrophins administered subcutaneously and intramuscularly.
• Local side effects of subcutaneous and intramuscular urinary gonadotropins for Ovarian stimulation in in vitro fertilization: a prospective, randomized study.
• Serum vascular endothelial growth factor concentrations and Ovarian stromal blood flow are increased in women with polycystic ovaries.
• Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
• GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS.
• Should Cochrane reviews be performed during the development of new concepts?
• In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation.
• Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist.
• Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to Ovarian stimulation.
• A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders.
• Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism.
• Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize Pregnancy success in cycles with gonadotropin-releasing hormone agonist ...
• Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled Ovarian stimulation before in vitro fertilization in poor responders.
• Endogenous gonadotropin flare following microdose leuprolide (MDL) stimulation protocol does not correlate with in vitro fertilization (IVF) outcome.
• Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of Ovarian hyperstimulation syndrome in high-risk patients and leads ...
• Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-r...
• The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study.
• The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro f...
• Outcome of in vitro fertilization treatment in patients who electively inseminate a limited number of oocytes to avoid creating surplus human embryos for cryopreservat...
• GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
• Obstetrical complications in gestational carrier Pregnancies.
• An unusual anatomic variation of a unicornuate uterus with normal external Uterine morphology.
• Ovarian response in three consecutive in vitro fertilization cycles.

Schools

---

• University Of Ghana

Procedures Preformed

---

• Fluid Contrast Ultrasound
• Gynecologic Cancer Screening
• Hysteroscopy
• Myomectomy - Open and-or Laparoscopic
• View All

Conditions Treated

---

• Ectopic Pregnancy
• Encounters for High-Risk Pregnancies
• Endometriosis
• Female Infertility
• View All

Doctors Specialties

---

• Obstetrics
• Gynecology

Accepted Insurances

---

Education

---

• University of Ghana Medical School

Hospital

---

• Hartford Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Manocher Lashgari, MD This Doctor is OpenDoctor Recommended.
	Dr. Behzad Satvat, MD This Doctor is OpenDoctor Recommended.
	Dr. Gene D. Kirschenbaum, MD This Doctor is OpenDoctor Recommended.
	Dr. Beth E. Nelson, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrea B. Joyner, MD This Doctor is OpenDoctor Recommended.
	Dr. Maxine Klein, MD This Doctor is OpenDoctor Recommended.
	Dr. Reinaldo Figueroa, MD This Doctor is OpenDoctor Recommended.
	Dr. Walter Trymbulak, MD This Doctor is OpenDoctor Recommended.
	Dr. Maria Ellis, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog